info@clinicaloncologyjournal.com

Speciality

Bladder Cancer Bone Cancer Breast cancer Central Nervous System tumours Cervical Cancer Chemotherapy and radiotherapy Colorectal cancers Endometrial Cancer Endoscopic methods Esophageal Cancer Gallbladder Cancer Gastrointestinal Cancer General Oncology Gynecological cancers Haemato-oncology Head and Neck Oncology Kidney Cancer Leukemia Cancer Liver Cancer Lung cancers Lymphoma Melanoma/Skin Cancer Non-Hodgkin Lymphoma Nuclear medicine Palliative care Pancreatic Cancer Pediatric Cancer Prostate Cancer Psycho Oncology Radiation Oncology Radiological techniques and scans Sarcoma Skin Cancer Stomach (Gastric) Cancer Surgical Oncology Teenage and Young Adult Cancers Thoracic Oncology Thyroid Cancer Urological cancers

Articles

  • Issue: 1, Volume: 2

Jul 07, 2021

Provocative Question: “Does the Gut Microbiome Influence the Metastatic Cascade of Cancer?”

In this perspective article, we review novel and unresolved concepts related to the biology of cancer metastasis that may be reasonably connected and resolved through the study of alterations in the gut microbiome. We hope this perspective generates discussion and a research agenda that contributes to our understanding of metastatic dormancy, the development of the pre-metastatic niche, and metastatic endurance.

May 03, 2021

Outcome of Cervical Cancer Patients Treated with Concomitant Chemoradiation Followed by Moderate Dose Rate Brachytherapy

Objectives: Cervical cancer is one of the common gynecological cancers that have high mortality and morbidity rate in developing countries because of late presentation due to lack of awareness programs and limited medical facilities. Brachytherapy is one of the modalities in its treatment. Much Data is available in the literature for Low Dose Rate (LDR) and High Dose Rate (HDR) Brachytherapy (BT) with little published data for Moderate Dose Rate (MDR) BT.

Jan 15, 2021

Use of a Commercially Available 12-Gene Assay in the Treatment of Early-Stage Colorectal Cancer: Results from a Nationally Representative Survey of U.S. Oncologists

Background: The Oncotype DX Colon Cancer Assay is a 12-gene assay that measures recurrence risk in stage II and III colorectal cancer patients that help oncologists make treatment decisions. Although adjuvant chemotherapy for patients with resected stage III colorectal cancer is routinely recommended, its benefit remains controversial in stage II colorectal cancer patients; thus, the real-world use of Oncotype DX Colon is of great clinical interest. The purpose of this study was to investigate ...

  • Issue: 3, Volume: 1

Oct 30, 2020

Adenomyoepithelioma with Myoepithelial Carcinoma of the Breast: A Case Report

Adenomyoepithelioma (AME) with myoepithelial carcinoma of the breast is rare and diagnosed following histological and immunohistochemical analysis. In the present case study, we describe a 38-year-old female patient with malignant AME with ultrasonographic and core biopsy findings. Histopathology revealed biphasic tubular proliferation and epithelial cells with atypical nuclei with obvious pleomorphism, hyperchromasia, and frequent mitosis. Overall Ki-67 proliferation index reached 30%. The pat...

Jul 05, 2020

A New Perspective for Gastrointestinal Cancer Research-from Genome Analysis to Preemptive Medicine

A large number of genomic and post-genomic studies in this century have been conducted to provide insight into the molecular mechanisms of gastrointestinal carcinogenesis and precision medicine. However, the incidence and mortality associated with gastrointestinal cancer have been increasing in the higher age range. Here, this review presents preemptive medicine to delay or prevent the onset of gastrointestinal cancer through an intervention based on molecular biomarkers, including an individua...

  • Issue: 2, Volume: 1

Jun 25, 2020

Enteral Nutrition following Oesophagectomy

The weight loss is a common clinical condition occurred in patients with oesophageal cancer and it was present in 57% of patients at the time of diagnosis [1]. This weight loss is related to malignancy and insufficient oral intake secondary to dysphagia, and it can be increased by neoadjuvant therapies. The weight loss can persist at least 3 years after surgery [1]. Therefore, surgical patient candidate for oesophageal surgery should be nutritionally evaluated before the time of surgery to dete...

Jun 20, 2020

Extensive Refractory Isolated Multiple Nodal Recurrence of Ovarian Cancer Treated with Rapid Arc Radiotherapy Technique: A Case Series Study

Isolated nodal recurrence of ovarian cancer is infrequent. For selected patients cytoreductive surgery can improve the survival. The response rate for second line chemotherapy for recurrent ovarian cancer is around 50%–60%, 20%–30% and 10% in platinum-sensitive, platinum-resistant and platinum-refractory patients respectively. IMRT uses a computer algorithm to optimize dose to the target and minimize dose to organs at risk by modulating and shaping the beam either with static or dynamic beams.

Jun 10, 2020

Prevalence and Patterns of Gastrointestinal Cancers among Obese Patients, from a Teaching Hospital in Saudi Arabia

Objective: To determine the prevalence and patterns of gastrointestinal (GI) cancers among obese and non-obese patients. Background: Obesity is associated with many comorbidities. Several studies concluded that there is an association between obesity and different types of cancers. But the prevalence and patterns of GI cancers among obese patients need to be investigated.

Jun 03, 2020

Importance of Recombinant Protein L1 Papillomavirus 16 in the Treatment of Uterine Cancer

More than 100 types of papillomavirus have been identified so far, they are completely tissue-specific. About 5 of these infect the genital area from one person to another through sexual contact. Delayed proteins include L1 and L2, which form the virus capsid. Cervical cancer is the second most common cancer after breast cancer in women worldwide. Human papillomavirus (HPV) accounts for more than 2% of cervical cancers.Among them, about 15 carcinogenic genotypes have been identified as high-ris...

  • Issue: 1, Volume: 1

May 31, 2020

Refining Immunotherapy of Human B-cell Non-Hodgkin’s Lymphoma by CD19 CAR T Cell: Current and Future Perspectives

Non-Hodgkin’s Lymphoma (NHL) is responsible for 4% of all cancer cases in the United States, but its conventional treatment options have experienced limited success. Patients develop resistances to the standard chemotherapy, CHOP, as well as Rituximab, a chemosensitizing agent used in concert with CHOP. Chimeric antigen receptor T cell (CAR-T cell) therapy may be a viable option for patients with refractory/relapsed NHL. In this new immunotherapy, a CAR is genetically added to the surface of T ...

May 23, 2020

Stereotactic Ablative Radiotherapy for Early-Stage Primary Non Small Cell Lung Cancer

Background and purpose: Stereotactic Ablative Radiotherapy (SART) has been associated with both impressive early responses and high rates of early-stage NSCLC control. This article reviews the overall survival, local control, toxicity and failure of SART in patients with early-stage NSCLC. Material and methods: The systematic review was performed following PRISMA guidelines. Survival outcomes were evaluated for early-stage NSCLC. Local control and toxicity outcomes were evaluated for any centr...

May 07, 2020

Self-Perceived Attitudes Toward End-of-Life Care among Nurses Working in Acute Hospital in Kenya

Background: Despite of the fact that nurses play a key role in caring for dying patients, nurses describe themselves as lacking confidence in providing care for the dying. Aim: This study sought to assess nurses’ perceived attitudes toward end-of-life nursing care. Further, the study aimed to assess whether a relationship exists between work setting and nurses’ attitudes toward end-of-life nursing care.

Mar 05, 2020

Adenocarcinoma Admixed Neuroendocrine Carcinoma: A rare Case Report of 39 Years Old Women

Introduction: Neuroendocrine carcinoma coexisted with adenocarcinoma in cervix is very rare. This disease have a very poor prognosis and so far no standard treatment has been obtained. Case Illustration: A 39-years-old woman seeks medical attention with chief complaint of bleeding outside of menstruation. Ultrasound: EL (+) enlarged portio with a mass of 3.8 cm × 2.7 cm.

Feb 28, 2020

Prognostic Significance of Aurora Kinase Expression and it’s Correlation with Other Apoptotic-like Proteins in Oral Tongue Squamous Cell Carcinoma

Background: Aurora kinases represent a family of serine/threonine kinases with an important role in cell division regulation. We evaluated the association of Aurora Kinase-A (AURKA) and Aurora Kinase-B (AURKB) with other apoptotic-like proteins, clinicopathological factors and survival in a cohort of Oral Tongue Squamous Cell Carcinoma (OTSCC) patients. Methods: AURKA, AURKB, P53 and Survivin expression using immunohistochemistry, with a cut-off point of 10% was performed in 100 OTSCC patients.

Are you interested in submitting your research paper?

Thank you for choosing us. We recommend you to go through our guidelines before submitting the paper.

Submit Manuscript
Logo

Clinical Oncology Journal is the state-of-the-art platform to showcase medical journals across scientific community and a one-stop solution for publishing the manuscripts of varied medical specialities.

Main Links

Useful Links

Our Contacts

CLINICAL ONCOLOGY JOURNAL,
C/O Infact Publications LLC,
16192 Coastal Highway,
Lewes, Delaware 19958
USA

info@clinicaloncologyjournal.com
https://clinicaloncologyjournal.com